TNFSF11 and head and neck squamous cell carcinoma: Given that the integrin α2 expression positively correlated with RANKL expression in HNSCC patient samples (Fig. 1), RANKL and its downstream signaling molecule integrin α2 may be functional markers for aggressive HNSCC.